Primary Article
Multicenter Randomized Trial of Ofloxacin Versus Cefoxitin and Doxycycline in Outpatient Treatment of Pelvic Inflammatory Disease
ABSTRACT: A multicenter randomized comparative trial was done to assess the safety and efficacy of oral ofloxacin (400 mg twice daily for 10 days) versus cefoxitin (2 g intramuscularly) followed by doxycycline (100 mg twice daily orally for 10 days) for the outpatient treatment of uncomplicated pelvic inflammatory disease (PID)….